Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features (Q72801727)
Jump to navigation
Jump to search
scientific article published on 01 November 1994
Language | Label | Description | Also known as |
---|---|---|---|
English | Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features |
scientific article published on 01 November 1994 |
Statements
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features (English)
Barakat RR
Wong G
Vlamis V
1 November 1994